Young children using the t:slim X2 insulin pump with Control-IQ Technology system maintained target glucose levels for 3 hours longer than children using an insulin pump or daily injections with a ...
As Dexcom works to build a case for broader use of continuous glucose monitors, the company touted new data that point to CGM use for people with Type 2 diabetes. New results from a study funded by ...
Continuous glucose monitors and other connected technologies for diabetes management have traditionally been used overwhelmingly by people with Type 1 diabetes, though major devicemakers like Dexcom ...